The global irritable bowel syndrome treatment market size was valued at USD 3.48 billion in 2024 and is projected to reach ...

Irritable Bowel Syndrome (IBS) is a common yet often misunderstood digestive disorder that affects millions of people ...

Patients with irritable bowel syndrome are more likely to benefit from a diet that eliminates any food triggering an IgG ...

Dr Ray O’Connor takes a look at some of the most recent clinical studies on irritable bowel syndrome (IBS) ...

Recently, there has been strong interest in the therapeutic potential of probiotics for irritable bowel syndrome (IBS). At the same time, there is a rapidly growing body of evidence to support an ...

The following is a summary of “Improvement of irritable bowel syndrome with glucagon like peptide-1 receptor agonists: a ...

Lifestyle strategies and medications can also offer some relief. Irritable bowel syndrome (IBS) isn’t the same for everyone. While some suffer from constipation, others deal with diarrhea.

About Immuron Immuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and ...

Kyra Biemans tracks her poop daily each week and then transfers the data into an Excel sheet to create a color grid for her ...

1 Department of Anatomy, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia 2 Department of Internal Medicine, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia Introduction: ...